Errico M, Crozier R A, Plummer M R, Cowen D S
Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, NJ, Piscataway, USA.
Neuroscience. 2001;102(2):361-7. doi: 10.1016/s0306-4522(00)00460-7.
Medications that selectively increase 5-hydroxytryptamine are currently the most commonly prescribed antidepressants. However, it is not known which receptors for 5-hydroxytryptamine, nor which post-receptor cellular signals, mediate the antidepressant actions of 5-hydroxytryptamine. The hippocampus is highly innervated by serotonergic neurons and appears to be an ideal region of the brain for studying the antidepressant role of 5-hydroxytryptamine. Treatment with antidepressants has been shown to cause increased expression of proteins in the hippocampus that appear to be protective against stress-induced atrophy. This suggests a role for pathways, such as mitogen-activated protein kinase, that regulate protein synthesis. In the present study we found that 5-HT(7) receptors, expressed by cultured rat hippocampal neurons, couple to stimulation of the mitogen-activated protein kinase extracellular signal-regulated kinases ERK1 and ERK2. The 5-HT(1/7) receptor-selective agonist 5-carboxamidotryptamine maleate (5-CT) as well as the 5-HT(1A/7) receptor-selective agonists 8-hydroxy-N,N-dipropyl-aminotetralin (8-OH-DPAT) and N,N-dipropyl-5-carboxamidotryptamine maleate (dipropyl-5-CT) were found to activate extracellular signal-regulated kinase with equal efficacy to 5-HT. However, the EC(50) for 8-OH-DPAT was approximately 200-fold greater than that of 5-HT, a difference in potency consistent with the pharmacology of 5-HT(7), but not 5-HT(1A), receptors. Additionally, pretreatment with pertussis toxin, which would be expected to block the actions of 5-HT(1,) but not 5-HT(7,) receptors caused no inhibition. 4-Iodo-N-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]N-2-pyridinyl-benzamide hydrochloride (p-MPPI) and N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-cyclohexanecarb oxamide maleate (WAY-100635), antagonists selective for 5-HT(1A) receptors, similarly caused no inhibition of the activity of 5-HT.In summary, these studies are the first to demonstrate that 5-hydroxytryptamine activates the mitogen-activated protein kinase ERK in primary neuronal cultures. That 5-HT(7) receptors couple to activation of extracellular signal-regulated kinase in hippocampal neurons suggests a possible role for 5-HT(7) receptors in mediating some of the actions of antidepressants that increase 5-hydroxytryptamine.
选择性增加5-羟色胺的药物是目前最常用的抗抑郁药。然而,尚不清楚5-羟色胺的哪些受体,以及哪些受体后细胞信号介导了5-羟色胺的抗抑郁作用。海马体由血清素能神经元高度支配,似乎是研究5-羟色胺抗抑郁作用的理想脑区。已证明用抗抑郁药治疗可导致海马体中蛋白质表达增加,这些蛋白质似乎对压力诱导的萎缩具有保护作用。这表明有丝分裂原活化蛋白激酶等调节蛋白质合成的信号通路发挥了作用。在本研究中,我们发现培养的大鼠海马神经元表达的5-HT(7)受体与有丝分裂原活化蛋白激酶细胞外信号调节激酶ERK1和ERK2的刺激偶联。5-HT(1/7)受体选择性激动剂马来酸5-羧酰胺色胺(5-CT)以及5-HT(1A/7)受体选择性激动剂8-羟基-N,N-二丙基-氨基四氢萘(8-OH-DPAT)和马来酸N,N-二丙基-5-羧酰胺色胺(二丙基-5-CT)被发现以与5-HT相同的效力激活细胞外信号调节激酶。然而,8-OH-DPAT的EC(50)比5-HT大约高200倍,这种效价差异与5-HT(7)而非5-HT(1A)受体的药理学一致。此外,用百日咳毒素预处理,预期其会阻断5-HT(1)但不会阻断5-HT(7)受体的作用,并未产生抑制作用。4-碘-N-[2-[4-(甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶基-苯甲酰胺盐酸盐(p-MPPI)和N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶基-环己烷甲酰胺马来酸盐(WAY-100635),5-HT(1A)受体选择性拮抗剂,同样未对5-HT的活性产生抑制作用。总之,这些研究首次证明5-羟色胺在原代神经元培养物中激活有丝分裂原活化蛋白激酶ERK。5-HT(7)受体与海马神经元中细胞外信号调节激酶的激活偶联,表明5-HT(7)受体在介导一些增加5-羟色胺的抗抑郁药的作用中可能发挥作用。